For decades, biopharma executives have seen operational costs and complexities soar. As commercial pricing, reimbursement, and market access hurdles remain particularly difficult to overcome, CEOs are ...
Bala V Sathyanarayanan serves as EVP & CHRO at Greif, Inc (NYSE: GEF) & Chairman of the Board of Directors at Balmer Lawrie - Van Leer Ltd. Organizations face unprecedented opportunities and ...
For an organization to thrive, it must be committed to continual, positive change. The secret to this level of growth is implementing an organizational development (OD) strategy at your company.
Even the most well-intentioned companies pass through stages of organizational development, including periods of chaos. As long as that chaos does not immobilize the company, it can form the basis or ...
When organizations create conditions that enable people to experience daily progress and development, they simultaneously enhance performance and build resilience. Our bodies and minds are most ...
As requested in Section 1544 of the FY2025 National Defense Authorization Act, a National Academies of Sciences, Engineering, and Medicine consensus study will conduct an "evaluation of alternative ...